Randomized phase II study of S-1 dosing schedule for resected colorectal cancer
Số trang: 4
Loại file: pdf
Dung lượng: 400.13 KB
Lượt xem: 11
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Postoperative adjuvant chemotherapy for patients with stage III Colorectal cancer (CRC) is now internationally accepted as standard care for improving patient outcomes. The Adjuvant Chemotherapy Trial of S-1 for Colorectal Cancer (ACTS-CC) confirmed the non-inferiority of S-1 to tegafur/urcail/leucovorin in terms of overall survival and disease-free survival in patients with stage III CRC after curative surgery.
Nội dung trích xuất từ tài liệu:
Randomized phase II study of S-1 dosing schedule for resected colorectal cancer
Nội dung trích xuất từ tài liệu:
Randomized phase II study of S-1 dosing schedule for resected colorectal cancer
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Colorectal cancer Randomized phase II Dose schedule Overall survivalGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 166 0 0 -
6 trang 165 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 138 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 106 0 0 -
12 trang 86 0 0
-
19 trang 72 0 0
-
17 trang 60 0 0
-
9 trang 35 0 0
-
11 trang 34 0 0
-
12 trang 33 0 0